These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2690220)

  • 1. [Erythropoietin: current aspects and prospects].
    Allegra A; Buemi M; Corica F; Giacobbe MS; Frisina N; Ceruso D
    Recenti Prog Med; 1989 Oct; 80(10):531-6. PubMed ID: 2690220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
    Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
    J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erythropoietin substitution in anemic patients with rheumatoid arthritis?].
    Bommer J
    Dtsch Med Wochenschr; 1991 Sep; 116(37):1412. PubMed ID: 1889357
    [No Abstract]   [Full Text] [Related]  

  • 4. Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin.
    Birgegård G; Gudbjrönsson B; Hällgren R; Wide L
    Contrib Nephrol; 1991; 88():295-303; discussion 304-5. PubMed ID: 2040192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal insufficiency and erythropoietin].
    Takaku F
    Nihon Rinsho; 1974 Mar; 32(3):528-34. PubMed ID: 4603797
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients.
    Buemi M; Allegra A; Laganà A; Aloisi C; Privitera M; Morabito N; Frisina N
    Riv Eur Sci Med Farmacol; 1993; 15(5-6):195-7. PubMed ID: 7761669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin: mechanisms of action and indications for treatment.
    Vreugdenhil G; Frenken LA; Koene RA
    Neth J Med; 1993 Jun; 42(5-6):187-202. PubMed ID: 8377877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin in patients with anaemia in rheumatoid arthritis.
    Pavlović-Kentera V; Ruvidić R; Milenković P; Marinković D
    Scand J Haematol; 1979 Aug; 23(2):141-5. PubMed ID: 493876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis].
    Zhu Y; Ye D; Huang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):587-90. PubMed ID: 11225250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blunted erythropoietin response to anaemia in rheumatoid arthritis.
    Baer AN; Dessypris EN; Goldwasser E; Krantz SB
    Br J Haematol; 1987 Aug; 66(4):559-64. PubMed ID: 3663512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does anemia correction by rHuEPO improve uremic cardiopathy?
    Carletti P; Bibiano L; Boggi R; Taruscia D; Mioli V
    Kidney Int Suppl; 1993 Jun; 41():S70-1. PubMed ID: 8320949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of various factors that could have an impact on the treatment with erythropoietin of hemodialysis anemia].
    Fernández-Gallego J; Ramos B; Ruiz A; Contreras J; Alvarez Bustos G; López de Novales E
    Nefrologia; 2000; 20(2):164-70. PubMed ID: 10853198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of anaemia in rheumatoid arthritis by recombinant human erythropoietin.
    Tauchi T; Ohyashiki JH; Fujieda H; Lin KY; Ohyashiki K; Toyama K
    Br J Rheumatol; 1990 Jun; 29(3):235-6. PubMed ID: 2357513
    [No Abstract]   [Full Text] [Related]  

  • 14. [Erythropoietin--therapeutic option in chronic polyarthritis-induced anemia].
    Rave O; Wienands K
    Z Rheumatol; 1995; 54(1):50-5. PubMed ID: 7725810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron repletion as a contribution to erythropoietin treatment of anemia in rheumatoid arthritis.
    Vreugdenhil G; Nieuwenhuizen C; Van Eijk HG; Swaak AJ
    Am J Med; 1991 May; 90(5):662-3. PubMed ID: 2029033
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human erythropoietin (r-hu-EPO) treatment in patients with rheumatoid arthritis and anaemia of chronic disease (ACD).
    Swaak AJ; Nieuwenhuizen C; Vreugdenhil G
    Clin Exp Rheumatol; 1994; 12(5):577. PubMed ID: 7842542
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin.
    Gudbjörnsson B; Hällgren R; Wide L; Birgegård G
    Ann Rheum Dis; 1992 Jun; 51(6):747-52. PubMed ID: 1616357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin: evolving clinical applications.
    Abels RI; Rudnick SA
    Exp Hematol; 1991 Sep; 19(8):842-50. PubMed ID: 1868899
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum levels of erythropoietin in rheumatoid arthritis.
    Ward HP; Gordon B; Pickett JC
    J Lab Clin Med; 1969 Jul; 74(1):93-7. PubMed ID: 5789577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.